Microform holoprosencephaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280200OMIM:609637Q04.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Microform holoprosencephaly (also known as microform HPE or holoprosencephaly microform) is the mildest end of the holoprosencephaly (HPE) spectrum, a group of disorders resulting from incomplete division of the forebrain (prosencephalon) during early embryonic development. Unlike the more severe forms of holoprosencephaly (alobar, semilobar, and lobar), microform HPE is characterized by subtle midline facial abnormalities without the typical structural brain malformations seen on standard neuroimaging. Affected individuals may present with features such as a single central maxillary incisor (solitary median maxillary central incisor), hypotelorism (closely spaced eyes), midface hypoplasia, microcephaly, or anosmia (absent sense of smell). Cognitive function can range from normal to mildly impaired, though some individuals may have more significant neurological involvement. Microform HPE is caused by mutations in genes known to be involved in the holoprosencephaly spectrum, including SHH (Sonic Hedgehog), ZIC2, SIX3, TGIF1, and others. The condition demonstrates significant phenotypic variability, even within the same family carrying the same mutation, which is a hallmark of the HPE spectrum. Environmental factors such as maternal diabetes may also contribute to disease expression. Chromosomal abnormalities, including deletions and duplications affecting HPE-related loci, can also be causative. There is no cure for microform holoprosencephaly, and management is supportive and symptom-based. Dental anomalies, particularly the single central incisor, may require orthodontic intervention. Endocrine evaluation is recommended, as some patients may have pituitary dysfunction leading to growth hormone deficiency or other hormonal imbalances. Genetic counseling is essential for affected families, given the autosomal dominant inheritance pattern with variable expressivity and reduced penetrance observed in many cases. Regular developmental monitoring and neuropsychological assessment may be beneficial for children with this condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Solitary median maxillary central incisorHP:0006315Midnasal stenosisHP:0010644Tented upper lip vermilionHP:0010804
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Microform holoprosencephaly.

View clinical trials →

No actively recruiting trials found for Microform holoprosencephaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Microform holoprosencephaly community →

No specialists are currently listed for Microform holoprosencephaly.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Microform holoprosencephaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Microform holoprosencephalyForum →

No community posts yet. Be the first to share your experience with Microform holoprosencephaly.

Start the conversation →

Latest news about Microform holoprosencephaly

No recent news articles for Microform holoprosencephaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Microform holoprosencephaly

What is Microform holoprosencephaly?

Microform holoprosencephaly (also known as microform HPE or holoprosencephaly microform) is the mildest end of the holoprosencephaly (HPE) spectrum, a group of disorders resulting from incomplete division of the forebrain (prosencephalon) during early embryonic development. Unlike the more severe forms of holoprosencephaly (alobar, semilobar, and lobar), microform HPE is characterized by subtle midline facial abnormalities without the typical structural brain malformations seen on standard neuroimaging. Affected individuals may present with features such as a single central maxillary incisor (

At what age does Microform holoprosencephaly typically begin?

Typical onset of Microform holoprosencephaly is neonatal. Age of onset can vary across affected individuals.